#1 Startup Dataset
Growth rates, revenue data, direct competitors and contact details.
Nathan Fitzsimmons Email
Acting CEO . Dyve Biosciences
Thousand Oaks, CA
Locationn*****************@dyvebio.com
Primary EmailHow to contact Nathan Fitzsimmons
Join and see Nathan's contact info for free!Current Roles
Employees:
16Revenue:
$2.5MAbout
About Dyve Biosciences Dyve is a clinical stage biotech company with its lead asset, DYV700, currently completing a 20-center, 100-patient, Phase 2 clinical study for the treatment of acute gout. Dyve’s transdermal delivery science platform overturns the traditional limitations of administering therapies. It combines the fast onset of action of an injection with the extended duration and bioavailability of an oral pill – creating ideal PK/PD parameters and an optimal drug profile. Dyve has a robust internal pipeline of novel drugs and a research collaboration in place with a Top 10 Pharmaceutical Company on a separate set of target NCEs. For more information, please visit www.dyvebio.com. Corporate Contact Jim McGee Dyve Biosciences, Inc. 805-857-6449 jim.mcgee@dyvebio.com Investor Contact Corey Davis LifeSci Advisors, LLC 212-915-2577 cdavis@lifesciadvisors.comDyve Biosciences Address
2545 W Hillcrest DrThousand Oaks, CA